Cognitive Screening Test Using Adaptive Visual Subtests
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for evaluating cognitive function are inadequate for distinguishing between cognitively impaired and non-impaired individuals, particularly in identifying preclinical Alzheimer's Disease and amyloid deposition.
Innovation Solution
A method and system for quantitative assessment of functional impairment that presents visual scenes and cues to subjects, determines equilibrated scene parameters, and generates output for assessing attention, memory, and other cognitive functions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional cognitive testing methods are used, then the test administration is simple, but the ability to detect preclinical Alzheimer's Disease and distinguish cognitively impaired from non-impaired individuals is insufficient
Solution Approach 1:
The cognitive assessment is divided into multiple independent subtests (Visual Salience, Shape Discrimination, Visual Motor Reaction Time, Adaptive Motor Response), each targeting specific cognitive domains. This segmentation allows comprehensive evaluation of different cognitive functions while maintaining manageable complexity through modular test components.
Solution Approach 2:
The system integrates multiple assessment functions into a single unified platform that can detect various cognitive impairments, track progression over time, and identify preclinical Alzheimer's Disease. The same system architecture serves multiple diagnostic and monitoring purposes, improving detection accuracy without proportionally increasing complexity.
2Measurement precision
If quantitative assessment methods are implemented, then the measurement precision of cognitive function improves, but the ease of operation and implementation becomes more difficult
Solution Approach 1:
The system provides automated scoring and interpretation of test results, with feedback mechanisms that guide administrators through the testing process and explain the significance of quantitative findings. This feedback system simplifies operation by handling complex data analysis automatically while maintaining high measurement precision through standardized quantitative algorithms.
Solution Approach 2:
Manual cognitive assessment methods are replaced with an automated computer-based system that objectively measures cognitive functions through standardized stimuli and response protocols. This substitution of mechanical/manual assessment with automated digital measurement improves quantification precision while reducing the operational burden on administrators through automated scoring and interpretation.
3Measurement precision
If comprehensive cognitive assessment is conducted, then the detection of cognitive impairment improves, but the time required for testing increases
Solution Approach 1:
The test system dynamically adapts to the examinee's performance, allowing flexible sequencing and selection of subtests based on initial results and clinical needs. This dynamic approach enables comprehensive cognitive assessment while reducing testing time by focusing on the most relevant domains and avoiding redundant testing in areas where normal performance is demonstrated.
Data Source
AI summary
The Cognivue Test subtest scores may detect Preclinical Alzheimer's Disease (AD). This effect appears to be explained by: Adaptive Motor Response, Visual Salience, Shape Discrimination, and Visual Motor Reaction Time. Notably, the Preclinical AD group is also different from mild cognitive impairment MCI/AD and non-AD impairment across all tests (except Visual Motor Reaction Time) supporting the premise that the Cognivue Test can discriminate impaired individuals of any etiology from non-impaired individuals and further can identify non-impaired individuals who have amyloid deposition.